SCHEMBL7962407

SCHEMBL7962407

COC(=O)N1C2C=CC1C(S(=O)(=O)c1ccccc1)=C2c1ccnc(Cl)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3C3 Q8NEB9 3/20 0.34
RORB Q92753 2/20 0.34
RORC P51449 1/20 0.34
ALDH1A1 P00352 3/20 0.33
ROCK1 Q13464 3/20 0.32
ROCK2 O75116 1/20 0.32
AAK1 Q2M2I8 1/20 0.32
CYP3A4 P08684 2/20 0.32
PRKACA P17612 1/20 0.32
SLC40A1 Q9NP59 1/20 0.31
PTGS2 P35354 2/20 0.31
CYP2C9 P11712 1/20 0.31
NAMPT P43490 1/20 0.31
KDM4E B2RXH2 1/20 0.31
GAA P10253 1/20 0.31
PKM P14618 1/20 0.31
HPGD P15428 1/20 0.31
ALKBH2 Q6NS38 1/20 0.31
ALKBH5 Q6P6C2 1/20 0.31
FTO Q9C0B1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7955502 0.85 NAMPT (0.39) ALDH1A1CYP2C9NAMPTKDM4EGAA
SCHEMBL7948059 0.84 HTR6 (0.35) ALDH1A1CYP3A4CYP2C9KDM4EGAA
SCHEMBL7955674 0.81 KMT2A (0.36) ALDH1A1SLC40A1PTGS2CYP2C9NAMPT
SCHEMBL7957857 0.79 APLNR (0.35) NAMPT
SCHEMBL7962359 0.61 NAMPT (0.42) ALDH1A1CYP2C9NAMPTKDM4EGAA
SCHEMBL11485043 0.60 ALDH1A1 (0.40) PIK3C3ALDH1A1SLC40A1NAMPTKDM4E
SCHEMBL7957880 0.59 SMARCA2 (0.35)
SCHEMBL4001581 0.58 NR1H2 (0.49) RORCPTGS2CYP2C9
SCHEMBL3862319 0.58 ALDH1A1 (0.50) ALDH1A1PTGS2KDM4EGAAPKM
SCHEMBL16916914 0.58 GRM4 (0.44) PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6255490-B1 TREATING DISORDERS ASSOCIATED WITH CHANGES IN CHOLINERGIC ACTIVITY; NON-OPIATE BASED ANALGESIC FOR MODERATE TO SEVERE PAIN EQUALLY OR EXCEEDING THE POTENCY OF OPIATE ANALGESICS, YET LACKING ADDICTIVE SIDE EFFECTS UNIVERSITY OF VIRGINIA 2001-07-03 US disclosed
US-6117889-A 7-Azabicyclo-[2.2.1]-heptane and -heptene derivatives as analgesics and anti-inflammatory agents UNIVERSITY OF VIRGINIA (US) 2000-09-12 US disclosed
US-6060473-A 7-azabicyclo[2.2.1]-heptane and -heptene derivatives as cholinergic receptor ligands UCB S.A. - DTB (BE) 2000-05-09 US disclosed
EP-0778835-A4 7-AZABICYCLO 2.2.1]-HEPTANE AND -HEPTENE DERIVATIVES AS CHOLINERGIC RECEPTOR LIGANDS UNIV VIRGINIA (US) 1999-02-03 EP disclosed
EP-0778835-A1 7-AZABICYCLO 2.2.1]-HEPTANE AND -HEPTENE DERIVATIVES AS CHOLINERGIC RECEPTOR LIGANDS UNIVERSITY OF VIRGINIA (US) 1997-06-18 EP disclosed
WO-1996006093-A1 7-AZABICYCLO[2.2.1]-HEPTANE AND -HEPTENE DERIVATIVES AS CHOLINERGIC RECEPTOR LIGANDS UNIVERSITY OF VIRGINIA (US) 1996-02-29 WO disclosed
EP-0691971-A1 7-AZABICYCLO- 2.2.1]-HEPTANE AND -HEPTENE DERIVATIVES AS ANALGESICS AND ANTI-INFLAMMATORY AGENTS UNIVERSITY OF VIRGINIA (US) 1996-01-17 EP disclosed
WO-1994022868-A1 7-AZABICYCLO-[2.2.1]-HEPTANE AND -HEPTENE DERIVATIVES AS ANALGESICS AND ANTI-INFLAMMATORY AGENTS UNIVERSITY OF VIRGINIA (US) 1994-10-13 WO disclosed